Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial-Reference-Cited by-同舟云学术

Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial

Published:2019-01-01 Issue:1 Volume:36 Page:867-874
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Zhou Jun¹,Li Linlin²,Li Xing³,Yu Qian¹,Cui Shaowei¹,Shu Kunpeng²,Liu Jianjun¹²,Liu Jie¹²,Ding Degang¹²³,Du Tao¹²³

Affiliation:

1. Department of Urology, Henan University People's Hospital, Zhengzhou, P.R. China;

2. Department of Urology, Henan Provincial People's Hospital, Zhengzhou, P.R. China;

3. Department of Urology, Zhengzhou University People's Hospital, Zhengzhou, P.R. China

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2019.1646929

Reference41 articles.

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0: Estimated cancer incidence, mortality and prevalence worldwide in 2012, 2013, 2015. http://globocan.iarc.fr/Default.aspx.

2. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old

3. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

4. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

5. Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review;Urologic Oncology: Seminars and Original Investigations;2024-09

2. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

3. Effect of different infusion modes of pirarubicin on recurrence rate and adverse reactions in patients with postoperative chemotherapy for bladder cancer: A Meta-Analysis;2024-02-19

4. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells;International Journal of Hyperthermia;2023-10-23

5. Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical study;Asia-Pacific Journal of Clinical Oncology;2023-01-19